Lansdowne Partners (UK)’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Lansdowne Partners (UK)’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,805,161	Closed	-$1.24M	–	74
2015 Q2	$1.24M	Hold	3,805,161	–	–	0.01%	50
2015 Q1	$1.67M	Hold	3,805,161	–	–	0.02%	39
2014 Q4	$1.21M	Hold	3,805,161	–	–	0.01%	38
2014 Q3	$2.61M	Hold	3,805,161	–	–	0.02%	36
2014 Q2	$3.5M	Buy	+3,805,161	New	+$3.98M	0.03%	33

Lansdowne Partners (UK)'s RGDX Position: Q3 2015 in Review

Lansdowne Partners (UK) sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 3,805,161 shares — an estimated $1.24M sold.

Lansdowne Partners (UK) first reported a position in RGDX in Q2 2014 and held it in 5 quarters. The position peaked at $3.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

Lansdowne Partners (UK) reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
Lansdowne Partners (UK) sold 3,805,161 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $1.24M.
Lansdowne Partners (UK) first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2014 and held it in 5 quarters.
Lansdowne Partners (UK)'s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $3.5M in Q2 2014.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Lansdowne Partners (UK)'s 13F filing for Q3 2015, filed 13 Nov 2015.